PD-1/PD-L1 inhibitor sequence
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PD-1/PD-L1 inhibitor sequence, covering 2022-04-11 to 2022-04-11. Get the full timeline:
Most recent: Clinical Trial Update: Sequential PD-1/PD-L1 Inhibitor and LENvatinib in TLCT and Refractory Hepatoblastoma After Chemotherapy [Phase 2, Phase 3]